Sign in
Not yet taking people in United StatesNo phase

Tests a decision aid for heart protection in cancer survivors

Tests a decision aid for heart care in adults with heart disease risk.

Key facts

Who runs it
Medical College of Wisconsin
Where
Milwaukee, United StatesSee the site
Trial code
Registry title
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Status
Not yet recruiting
People taking part
60 people, planned
Starts
Dec 2027
Expected to end
Dec 2029
Type of study
Observational, 2 groups
Treatments tested
  • Clinical Decision Aid
  • Standard Care
Record updated
3 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had cancer, have not yet seen a cardiologist about heart risk since the diagnosis, and are at medium to very high risk of heart disease.

Age
18 years or older.
Sex
All sexes can join.
Disease stage
A history of cancer, with intermediate, high, or very high risk of cardiovascular disease.
Earlier treatment
Must not have seen a cardiologist to assess cardiovascular risk since the cancer diagnosis.

Main reasons for not taking part

  • Under 18 years old
  • No personal history of cancer
  • Heart muscle disease (cardiomyopathy) diagnosed after the cancer diagnosis
  • Documented cognitive impairment
  • Unable or unwilling to sign the informed consent form

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients ≥18 years with a history of cancer
  • Have not previously visited a cardiologist to assess cardiovascular risk after cancer diagnosis
  • Clinically at intermediate, high, or very high risk for cardiovascular diseases determined based on imprecise clinical risk models, such as those used for cardiac dysfunction
  • Ability to understand a written informed consent form, and willing to sign it prior to study registration

Who cannot take part

  • Without a personal history of cancer
  • Existing cardiomyopathy diagnosed after cancer diagnosis
  • Documented cognitive impairment
  • Patient <18 years
  • Patient or patient representative who is unable and unwilling to sign the informed consent form

Where in United States

  • Froedtert & the Medical College of WisconsinMilwaukee, United StatesContact: Yee Chung Chen, MD (principal investigator)Not yet recruiting

About the trial

What the trial wants to find out

This is a single-center, double-arm, open-label, randomized feasibility study that will determine whether a novel clinical decision aid accessed via the electronic health record will be acceptable to both cancer survivors and their cardiologists, will favorably impact appropriate medication use and cardiac imaging surveillance, and will improve clinician and patient decision-making, perception, and behavior towards cardioprotective medication usage and cardiovascular disease imaging utilization.

The 2 groups in the trial

  • Clinical Decision Aid Group

    In this group, physicians will use standard care plus the clinical decision aid.

    Treatment: Clinical Decision Aid

  • Control Group

    In this group, physicians will use standard care only.

    Treatment: Standard Care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Plain-language title
Tests a decision aid for heart protection in cancer survivorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
3 November 2026